Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Intratumoral Immunotherapy: Using the Tumor as the Remedy

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Starting the fight in the tumor: Principles for intratumoral immunotherapy
Aurelien Marabelle
Inst. Gustave Roussy, Villejuif, France
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
Can all cancers be treated by intratumoral immunotherapy?
Thierry de Baere
Gustave Roussy, Villejuif Cedex, France
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
Early and late immune analysis post intratumoral TLR 9 agonist in combination with ipilimumab in patients with anti PD-1 refractory melanoma
Adi Diab
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
If losing Batf3-DC makes anti-PD1 fail, will bringing Batf3-DC to the tumor make anti-PD1 work?
Joshua D Brody
Icahn School Of Medicine At Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4